Plus Therapeutics PSTV

Annual report 2025
added 03-12-2026

Plus Therapeutics DIO Ratio 2011-2026 | PSTV

Annual DIO Ratio Plus Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	937	881	501	492	600	394	290	316

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
937	290	551

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 320.13	-3.98 %	$ 41.9 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.81	0.6 %	$ 1.02 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.35	-12.9 %	$ 347 M	USA
	Aquestive Therapeutics AQST	120	$ 4.26	0.47 %	$ 456 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Arcutis Biotherapeutics ARQT	185	$ 24.19	-1.59 %	$ 3.08 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.61	8.05 %	$ 428 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	BioXcel Therapeutics BTAI	1.56 K	$ 1.07	1.9 %	$ 13.1 M	USA
	ChromaDex Corporation CDXC	69.7	-	-0.88 %	$ 598 M	USA